Michel Therin, DVM and PhD, has extensive experience in the definition and implementation of international Medtech deployment strategies.

Formerly President of the Advanced Therapies Division of Siemens Healthineers, he defined and led the development strategy of the interventional imaging business, focusing on oncology, neurology, and cardiovascular care, and was actively involved in the acquisition of Corindus and Varian for a total of nearly €18 billion. He also spent twelve years at Medtronic as Global Vice President & General Manager, in charge of the development and commercialization of innovative surgical devices.

At Floreane Medical Implants, as Vice President of Research and Development and General Manager for 9 years, Michel Therin invented, developed and launched numerous breakthrough innovations in the field of abdominal and pelvic reconstruction that quickly gained international recognition, leading to the acquisition of the company by Tyco Healthcare.

Education: Michel Therin holds a double doctorate in veterinary medicine (Ecole Nationale Vétérinaire de Maison Alfort) and in biomedical engineering (Paris XIII). He is the author of more than 20 publications in international peer reviewed medical journals and has been a speaker at more than 100 international medical conferences.